Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells

Published:2002-05 Issue:2 Volume:179 Page:151-156
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Sadava David,Phillips Tiphanie,Lin Cindy,Kane Susan E

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Lung Cancer: Principles and Practice;Pass,2000

2. Therapeutic advances in SCLC;Kalemkerian;Expert Opin. Invest. Drugs,2000

3. Drug resistance in lung cancer;Nishio;Curr. Opin. Oncol.,1999

4. Resistance mechanisms in human lung cancer;Mattern;Invas. Metas.,1995

5. Qinghaosu (artemisinin): an antimalarial drug from China;Klayman;Science,1985

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review;International Journal of Nanomedicine;2024-09

2. Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases;Frontiers in Pharmacology;2024-03-04

3. Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy;Lung Cancer;2024-03

4. Fortschritte bei Studien zu weiteren pharmakologischen Wirkungen von Artemisininen;Von Artemisia annua L. zu Artemisininen;2024

5. An Overview of Dihydroartemisinin as a Promising Lead Compound for Development of Anticancer Agents;Mini-Reviews in Medicinal Chemistry;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3